Eric A. Wachter;Jamie Singer;Craig J. Eagle;H. Craig Dees
发明人:
Craig J. Eagle,H. Craig Dees,Eric A. Wachter,Jamie Singer
申请号：
US13416494
公开号：
US09107887B2
申请日:
2012.03.09
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic immunomodulatory anticancer agent. A further method for the treatment of cancer comprising administration of a therapeutically effective amount of an intralesional chemoablative pharmaceutical composition, or variant of said composition, in combination with a therapeutically effective amount of a systemic targeted anticancer agent. The present invention is further directed to pharmaceutical compositions for treatment of cancer. The intralesional chemoablative pharmaceutical composition can comprise an IL chemoablative agent comprising primarily a halogenated xanthene.
